LLY
Companies
Nyse American
Eli Lilly and Company
Health Care
$791.24
+$14.36 (+1.86%)
Price Chart
Overview
About LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Market Cap
$807.8B
Volume
2.4B
Avg. Volume
2.8B
P/E Ratio
31.985878
Dividend Yield
0.83%
Employees
41.0K
Company Information
Exchange
Nyse American
Sector
Health Care
Industry
Drug Manufacturers - General
Website
Latest News for LLY
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
June 18, 2025
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
June 11, 2025
Lilly to buy gene-editing partner Verve for $1.3 billion
June 17, 2025
Beyond Obesity: Eli Lilly's Genetic Medicine Bet On Verve Therapeutics
June 18, 2025
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?
June 19, 2025
Risk & Correlation Analysis
Market Correlation
0.59
Low Correlation
Volatility
Medium (0.32)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LLY shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$807.8B
Volume2.4B
P/E Ratio31.99
Dividend Yield0.83%
Important Dates
Next Dividend
March 10, 2025Next Earnings
August 6, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025